Authors


National Association of Medication Access & Patient Safety

Latest:

What is a Patient Advocate?

Health care advocates provide a vital service for patients who are managing chronic conditions.


dvm360 Staff

Latest:

FDA Approves Broad Spectrum Parasite Protection for Cats

The NexGard COMBO topical solution from Boehringer Ingelheim helps protect cats from tapeworms and other intestinal parasites like fleas, ticks, and heartworms.


Fazila Rajab, MD

Latest:

What You Need to Know About the Albuterol Shortage

The FDA is working quickly to address shortages of the form used in nebulizers.


Roma Sharma

Latest:

How to Help Make Health Equity a Reality

CMS and state officials are using payment incentives, data collection and program requirements to start edging the lofty ideals of health equity toward reality.


Jasmine Tankard, PharmD Candidate 2021

Latest:

Azacitidine Tablets for Acute Myeloid Leukemia

The FDA approved azacitidine tablets (Onureg; Celgene Corporation) on September 1, 2020


Hayden E. Klein

Latest:

Video: Top Tips for Patients to Encourage Healthful Diet and Lifestyle

Sharing concrete steps and suggestions can help ease the way for patients looking to transition to a more healthful lifestyle.


Roy Walton, PharmD candidate

Latest:

Daridorexant Receives Approval for Insomnia Treatment

Daridorexant demonstrated significant reduction in daytime sleepiness among other measures.


James B. Leonard, PharmD, DABAT

Latest:

Case Study: Treating Infants for Cannabis Exposure

As more and more states legalize recreational marijuana, caregivers need to be vigilant about keeping products out of the reach of children.



Charmaine Yuan

Latest:

Current and Future Treatments for Hidradenitis Suppurativa

Hidradenitis suppurativa is a chronic inflammatory skin condition that presents with painful, deep, and inflamed lesions found in flexural, apocrine gland-bearing sites.


Bennett Waxse, MD, PhD

Latest:

Examining the US Response to the Mpox Outbreak

By way of natural immunity, vaccination, and behavior change, the majority of the 30,861 documented cases and 54 deaths were confined to 2022, and the epidemic curve portrays a picture of success.


Cassi Prosper, CPhT

Latest:

USP <797> Updated Guidelines

The long-awaited revised USP <797> guidelines will become official on November 1, 2023.


Nicolette Bruno, BPS, PharmD Candidate

Latest:

Probiotics for the Prevention of Pediatric Antibiotic-Associated Diarrhea

Evidence of the relationship between probiotics and antibiotics is lacking.


Lisette Hilton

Latest:

Medical Misinformation Consequences in Health Care

The COVID-19 pandemic and social media have resulted in extreme levels of misinformation.


Megan Gray, PharmD

Latest:

Relyvrio: A New FDA-Approved Treatment for Patients With ALS

Relyvrio is intended to slow the disease progression of amyotrophic lateral sclerosis.


Douglas Newton, MD, MPH

Latest:

Navigating and Treating 'New Year Depression' in Patients

There may not be a diagnosis for ‘New Year Depression,’ but about 10% to 20% of individuals in the US may get a milder form of these winter blues.


Luz Rosario, PharmD candidate

Latest:

Navigating Pediatric ADHD Medication Shortages

Stimulant medications are the first-line pharmacologic therapy for ADHD, but many of these medications are currently in short supply.


David Cates, PhD

Latest:

Ethical, Practical Considerations of Exemptions to Employer Vaccine Mandates for Anxiety

Does anxiety justify an exemption from vaccine mandates among health care workers?


Emily Diseroad, PharmD, BCPPS

Latest:

Review: Harmful Excipients for Pediatric Patients

Evidence suggests some pharmaceutical excipients in medications may have adverse effects on pediatric patients. Here’s what you should know.


Mike Gladstone

Latest:

Payers Need to Make Effort for Improvements in Biosimilars

Efforts to improve education on biosimilars are a start, but payer policies must catch up to ensure real change.


Youssef Bessada, PharmD

Latest:

Fenfluramine for the Treatment of Seizures Associated With Dravet Syndrome

On June 25, 2020, fenfluramine (Fintepla) was approved for the treatment of seizures associated with Dravet syndrome in patients 2 years and older.


Edgar Galvan

Latest:

The Future Looks Busy for Pharmacy Technicians in Immunization Programs

During COVID-19, pharmacy technicians helped keep immunization programs running.


Zoe Wainer, MBBS, PhD

Latest:

Mind-Body Resilience for Women: A Focus on Depression

Developing innovative solutions for women with depression, accounting for differences in gender and sex, are critically important


Leslie Moore, CPhT

Latest:

What Does an Oncology Pharmacy Technician Do?

From compounding to cleaning, oncology pharmacy technicians take on key responsibilities in infusion centers.


Victor Agbafe, B.A.

Latest:

How Can Improving Provider-Patient Relationships Help Reverse Chronic Disease?

The existing approach to disease management may be ill-suited to address the dynamic and diverse factors at play when it comes to chronic illness.


Wade Tung, PharmD candidate

Latest:

Review of FDA Approvals for Pediatric Obesity Management

GLP-1 receptor agonists, used to manage diabetes, are now being used for obesity in children and adolescents.


Jessica Calihan, MD

Latest:

Cannabinoid Hyperemesis Syndrome: Diagnosis and Management

A deep dive for pharmacists into this frequently debilitating disorder


Mary Scoviak

Latest:

Simplifying Widespread Itch Care with Targeted Solutions

Matthew Zirwas, MD, shares his step-by-step pearls for quelling the pruritic skin condition.


Hooman Kashi, PharmD candidate

Latest:

Abrocitinib for Atopic Dermatitis

The drug’s approval was based on the results of 3 clinical trials.


Bailey Smith, PharmD

Latest:

Navigating Pediatric ADHD Medication Shortages

Stimulant medications are the first-line pharmacologic therapy for ADHD, but many of these medications are currently in short supply.

© 2024 MJH Life Sciences

All rights reserved.